Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Whole genome sequencing to study the phylogenetic structure of serotype a Haemophilus influenzae recovered from patients in Canada.

Tsang RSW, Shuel M, Ahmad T, Hayden K, Knox N, Van Domselaar G, Hoang L, Tyrrell GJ, Minion J, Van Caeseele P, Kus JV, Ulanova M, Lefebvre B, Haldane D, Garceau R, German G, Zahariadis G, Hanley B, Kandola K, Patterson M.

Can J Microbiol. 2019 Oct 29:1-12. doi: 10.1139/cjm-2019-0406. [Epub ahead of print]

PMID:
31661630
2.

Increase in ST-11 serogroup W Neisseria meningitidis invasive meningococcal disease in Canada, 2016-2018.

Tsang RS, Hoang L, Tyrrell GJ, Minion J, Van Caeseele P, Kus JV, Lefebvre B, Haldane D, Garceau R, German G, Zahariadis G, Hanley B.

Can Commun Dis Rep. 2019 Jun 6;45(6):164-169. doi: 10.14745/ccdr.v45i06a04. eCollection 2019 Jun 6.

3.

Multidrug-resistant and extensively drug-resistant Neisseria gonorrhoeae in Canada, 2012-2016.

Martin I, Sawatzky P, Allen V, Lefebvre B, Hoang L, Naidu P, Minion J, Van Caeseele P, Haldane D, Gad RR, Zahariadis G, Corriveau A, German G, Tomas K, Mulvey MR.

Can Commun Dis Rep. 2019 Feb 7;45(2-3):45-53. doi: 10.14745/ccdr.v45i23a01. eCollection 2019 Feb 7.

4.

Transnational access to large prospective cohorts in Europe: Current trends and unmet needs.

Simell BA, Törnwall OM, Hämäläinen I, Wichmann HE, Anton G, Brennan P, Bouvard L, Slimani N, Moskal A, Gunter M, Zatloukal K, Minion JT, Soini S, Mayrhofer MT, Murtagh MJ, van Ommen GJ, Johansson M, Perola M; BBMRI-LPC Consortium (FP7 GA no. 313010).

N Biotechnol. 2019 Mar 25;49:98-103. doi: 10.1016/j.nbt.2018.10.001. Epub 2018 Oct 17.

PMID:
30342241
5.

The ethics conundrum in Recall by Genotype (RbG) research: Perspectives from birth cohort participants.

Minion JT, Butcher F, Timpson N, Murtagh MJ.

PLoS One. 2018 Aug 16;13(8):e0202502. doi: 10.1371/journal.pone.0202502. eCollection 2018.

6.

The evolving epidemiology of Clostridium difficile infection in Canadian hospitals during a postepidemic period (2009-2015).

Katz KC, Golding GR, Choi KB, Pelude L, Amaratunga KR, Taljaard M, Alexandre S, Collet JC, Davis I, Du T, Evans GA, Frenette C, Gravel D, Hota S, Kibsey P, Langley JM, Lee BE, Lemieux C, Longtin Y, Mertz D, Mieusement LMD, Minion J, Moore DL, Mulvey MR, Richardson S, Science M, Simor AE, Stagg P, Suh KN, Taylor G, Wong A, Thampi N; Canadian Nosocomial Infection Surveillance Program.

CMAJ. 2018 Jun 25;190(25):E758-E765. doi: 10.1503/cmaj.180013.

7.

Blastomycosis in Southern Saskatchewan 2000-2015: Unique presentations and disease characteristics.

Lohrenz S, Minion J, Pandey M, Karunakaran K.

Med Mycol. 2018 Oct 1;56(7):787-795. doi: 10.1093/mmy/myx131.

PMID:
29924358
8.

Disseminated Exophiala dermatitidis causing septic arthritis and osteomyelitis.

Lang R, Minion J, Skinner S, Wong A.

BMC Infect Dis. 2018 Jun 4;18(1):255. doi: 10.1186/s12879-018-3171-0.

9.

Canadian recommendations for laboratory interpretation of multiple or extensive drug resistance in clinical isolates of Enterobacteriaceae, Acinetobacter species and Pseudomonas aeruginosa.

German GJ, Gilmour M, Tipples G, Adam HJ, Almohri H, Bullard J, Dingle T, Farrell D, Girouard G, Haldane D, Hoang L, Levett PN, Melano R, Minion J, Needle R, Patel SN, Rennie R, Reyes RC, Longtin J, Mulvey MR.

Can Commun Dis Rep. 2018 Jan 4;44(1):29-34. eCollection 2018 Jan 4.

10.

Better governance, better access: practising responsible data sharing in the METADAC governance infrastructure.

Murtagh MJ, Blell MT, Butters OW, Cowley L, Dove ES, Goodman A, Griggs RL, Hall A, Hallowell N, Kumari M, Mangino M, Maughan B, Mills MC, Minion JT, Murphy T, Prior G, Suderman M, Ring SM, Rogers NT, Roberts SJ, Van der Straeten C, Viney W, Wiltshire D, Wong A, Walker N, Burton PR.

Hum Genomics. 2018 Apr 26;12(1):24. doi: 10.1186/s40246-018-0154-6.

11.

Including all voices in international data-sharing governance.

Kaye J, Terry SF, Juengst E, Coy S, Harris JR, Chalmers D, Dove ES, Budin-Ljøsne I, Adebamowo C, Ogbe E, Bezuidenhout L, Morrison M, Minion JT, Murtagh MJ, Minari J, Teare H, Isasi R, Kato K, Rial-Sebbag E, Marshall P, Koenig B, Cambon-Thomsen A.

Hum Genomics. 2018 Mar 7;12(1):13. doi: 10.1186/s40246-018-0143-9.

12.

Cinnamomum zeylanicum bark essential oil induces cell wall remodelling and spindle defects in Candida albicans.

Shahina Z, El-Ganiny AM, Minion J, Whiteway M, Sultana T, Dahms TES.

Fungal Biol Biotechnol. 2018 Feb 9;5:3. doi: 10.1186/s40694-018-0046-5. eCollection 2018.

13.

The ECOUTER methodology for stakeholder engagement in translational research.

Murtagh MJ, Minion JT, Turner A, Wilson RC, Blell M, Ochieng C, Murtagh B, Roberts S, Butters OW, Burton PR.

BMC Med Ethics. 2017 Apr 4;18(1):24. doi: 10.1186/s12910-017-0167-z.

14.

Hematospermia in a returned traveler.

Lang R, Minion J, Wong A.

Can Urol Assoc J. 2017 Jan-Feb;11(1-2):E41-E43. doi: 10.5489/cuaj.3836. Epub 2017 Jan 12.

15.

Digital Methodology to implement the ECOUTER engagement process.

Wilson RC, Butters OW, Clark T, Minion J, Turner A, Murtagh MJ.

Version 2. F1000Res. 2016 Jun 9 [revised 2017 Jan 1];5:1307. doi: 10.12688/f1000research.8786.2. eCollection 2016.

16.

Multimethod study of a large-scale programme to improve patient safety using a harm-free care approach.

Power M, Brewster L, Parry G, Brotherton A, Minion J, Ozieranski P, McNicol S, Harrison A, Dixon-Woods M.

BMJ Open. 2016 Sep 22;6(9):e011886. doi: 10.1136/bmjopen-2016-011886.

17.

International Data Sharing in Practice: New Technologies Meet Old Governance.

Murtagh MJ, Turner A, Minion JT, Fay M, Burton PR.

Biopreserv Biobank. 2016 Jun;14(3):231-40. doi: 10.1089/bio.2016.0002. Epub 2016 May 20.

PMID:
27200470
18.

DataSHIELD: taking the analysis to the data, not the data to the analysis.

Gaye A, Marcon Y, Isaeva J, LaFlamme P, Turner A, Jones EM, Minion J, Boyd AW, Newby CJ, Nuotio ML, Wilson R, Butters O, Murtagh B, Demir I, Doiron D, Giepmans L, Wallace SE, Budin-Ljøsne I, Oliver Schmidt C, Boffetta P, Boniol M, Bota M, Carter KW, deKlerk N, Dibben C, Francis RW, Hiekkalinna T, Hveem K, Kvaløy K, Millar S, Perry IJ, Peters A, Phillips CM, Popham F, Raab G, Reischl E, Sheehan N, Waldenberger M, Perola M, van den Heuvel E, Macleod J, Knoppers BM, Stolk RP, Fortier I, Harris JR, Woffenbuttel BH, Murtagh MJ, Ferretti V, Burton PR.

Int J Epidemiol. 2014 Dec;43(6):1929-44. doi: 10.1093/ije/dyu188. Epub 2014 Sep 26.

19.

Running a hospital patient safety campaign: a qualitative study.

Ozieranski P, Robins V, Minion J, Willars J, Wright J, Weaver S, Martin GP, Woods MD.

J Health Organ Manag. 2014;28(4):562-75.

20.

Walkrounds in practice: corrupting or enhancing a quality improvement intervention? A qualitative study.

Martin G, Ozieranski P, Willars J, Charles K, Minion J, McKee L, Dixon-Woods M.

Jt Comm J Qual Patient Saf. 2014 Jul;40(7):303-10.

21.
22.

Between surveillance and subjectification: professionals and the governance of quality and patient safety in English hospitals.

Martin GP, Leslie M, Minion J, Willars J, Dixon-Woods M.

Soc Sci Med. 2013 Dec;99:80-8. doi: 10.1016/j.socscimed.2013.10.018. Epub 2013 Oct 30.

PMID:
24355474
23.

Improving quality and safety of care using "technovigilance": an ethnographic case study of secondary use of data from an electronic prescribing and decision support system.

Dixon-Woods M, Redwood S, Leslie M, Minion J, Martin GP, Coleman JJ.

Milbank Q. 2013 Sep;91(3):424-54. doi: 10.1111/1468-0009.12021.

24.

Culture and behaviour in the English National Health Service: overview of lessons from a large multimethod study.

Dixon-Woods M, Baker R, Charles K, Dawson J, Jerzembek G, Martin G, McCarthy I, McKee L, Minion J, Ozieranski P, Willars J, Wilkie P, West M.

BMJ Qual Saf. 2014 Feb;23(2):106-15. doi: 10.1136/bmjqs-2013-001947. Epub 2013 Sep 9. Review.

25.

Multidrug and extensively drug-resistant tuberculosis in Canada 1997-2008: demographic and disease characteristics.

Minion J, Gallant V, Wolfe J, Jamieson F, Long R.

PLoS One. 2013;8(1):e53466. doi: 10.1371/journal.pone.0053466. Epub 2013 Jan 9.

26.

Diagnostic accuracy and reproducibility of WHO-endorsed phenotypic drug susceptibility testing methods for first-line and second-line antituberculosis drugs.

Horne DJ, Pinto LM, Arentz M, Lin SY, Desmond E, Flores LL, Steingart KR, Minion J.

J Clin Microbiol. 2013 Feb;51(2):393-401. doi: 10.1128/JCM.02724-12. Epub 2012 Nov 14. Review.

27.

An updated systematic review and meta-analysis on the treatment of active tuberculosis in patients with HIV infection.

Ahmad Khan F, Minion J, Al-Motairi A, Benedetti A, Harries AD, Menzies D.

Clin Infect Dis. 2012 Oct;55(8):1154-63. Epub 2012 Jul 19. Review.

PMID:
22820541
28.

Promise versus reality: optimism bias in package inserts for tuberculosis diagnostics.

Denkinger CM, Grenier J, Minion J, Pai M.

J Clin Microbiol. 2012 Jul;50(7):2455-61. doi: 10.1128/JCM.00842-12. Epub 2012 May 9.

29.

Accuracy of rapid influenza diagnostic tests: a meta-analysis.

Chartrand C, Leeflang MM, Minion J, Brewer T, Pai M.

Ann Intern Med. 2012 Apr 3;156(7):500-11. doi: 10.7326/0003-4819-156-7-201204030-00403. Epub 2012 Feb 27. Review.

PMID:
22371850
30.

Microcolony culture techniques for tuberculosis diagnosis: a systematic review.

Leung E, Minion J, Benedetti A, Pai M, Menzies D.

Int J Tuberc Lung Dis. 2012 Jan;16(1):16-23, i-iii. doi: 10.5588/ijtld.10.0065. Epub 2011 Oct 6. Review.

PMID:
21986554
31.

Systematic review and meta-analysis of antigen detection tests for the diagnosis of tuberculosis.

Flores LL, Steingart KR, Dendukuri N, Schiller I, Minion J, Pai M, Ramsay A, Henry M, Laal S.

Clin Vaccine Immunol. 2011 Oct;18(10):1616-27. doi: 10.1128/CVI.05205-11. Epub 2011 Aug 10. Review.

32.

Comparison of LED and conventional fluorescence microscopy for detection of acid fast bacilli in a low-incidence setting.

Minion J, Pai M, Ramsay A, Menzies D, Greenaway C.

PLoS One. 2011;6(7):e22495. doi: 10.1371/journal.pone.0022495. Epub 2011 Jul 21.

33.

Diagnosing tuberculosis with urine lipoarabinomannan: systematic review and meta-analysis.

Minion J, Leung E, Talbot E, Dheda K, Pai M, Menzies D.

Eur Respir J. 2011 Dec;38(6):1398-405. doi: 10.1183/09031936.00025711. Epub 2011 Jun 23. Review.

34.

Fading of auramine-stained mycobacterial smears and implications for external quality assurance.

Minion J, Shenai S, Vadwai V, Tipnis T, Greenaway C, Menzies D, Ramsay A, Rodrigues C, Pai M.

J Clin Microbiol. 2011 May;49(5):2024-6. doi: 10.1128/JCM.00507-11. Epub 2011 Mar 23.

35.

Evaluation of light emitting diode-based fluorescence microscopy for the detection of mycobacteria in a tuberculosis-endemic region.

Shenai S, Minion J, Vadwai V, Tipnis T, Shetty S, Salvi A, Udwadia Z, Pai M, Rodrigues C.

Int J Tuberc Lung Dis. 2011 Apr;15(4):483-8. doi: 10.5588/ijtld.10.0229.

PMID:
21396207
36.

Rapid diagnostics for influenza: what are the options?

Chartrand C, Minion J, Pai M.

Future Microbiol. 2010 Oct;5(10):1451-5. doi: 10.2217/fmb.10.120. No abstract available.

37.

Microscopic-observation drug susceptibility and thin layer agar assays for the detection of drug resistant tuberculosis: a systematic review and meta-analysis.

Minion J, Leung E, Menzies D, Pai M.

Lancet Infect Dis. 2010 Oct;10(10):688-98. doi: 10.1016/S1473-3099(10)70165-1. Epub 2010 Aug 31. Review.

PMID:
20813587
38.

Bacteriophage assays for rifampicin resistance detection in Mycobacterium tuberculosis: updated meta-analysis.

Minion J, Pai M.

Int J Tuberc Lung Dis. 2010 Aug;14(8):941-51. Review.

PMID:
20626937
39.

Treatment of active tuberculosis in HIV-coinfected patients: a systematic review and meta-analysis.

Khan FA, Minion J, Pai M, Royce S, Burman W, Harries AD, Menzies D.

Clin Infect Dis. 2010 May 1;50(9):1288-99. doi: 10.1086/651686. Review.

PMID:
20353364
40.

New and improved tuberculosis diagnostics: evidence, policy, practice, and impact.

Pai M, Minion J, Steingart K, Ramsay A.

Curr Opin Pulm Med. 2010 May;16(3):271-84. doi: 10.1097/MCP.0b013e328338094f. Review.

PMID:
20224410
41.

Expanding the role of the microscopic observation drug susceptibility assay in tuberculosis and HIV management.

Minion J, Pai M.

Clin Infect Dis. 2010 Apr 1;50(7):997-9. doi: 10.1086/651082. No abstract available.

PMID:
20192726
42.

Evidence-based diagnosis of tuberculosis: resources for the medical microbiologist.

Minion J, Pai M.

Indian J Med Microbiol. 2010 Jan-Mar;28(1):2-4. doi: 10.4103/0255-0857.58719. No abstract available.

43.

Novel and improved technologies for tuberculosis diagnosis: progress and challenges.

Pai M, Minion J, Sohn H, Zwerling A, Perkins MD.

Clin Chest Med. 2009 Dec;30(4):701-16, viii. doi: 10.1016/j.ccm.2009.08.016. Review.

PMID:
19925962
44.

TB diagnostic tests: how do we figure out their costs?

Sohn H, Minion J, Albert H, Dheda K, Pai M.

Expert Rev Anti Infect Ther. 2009 Aug;7(6):723-33. doi: 10.1586/eri.09.52. Review.

PMID:
19681700
45.

Light-emitting diode technologies for TB diagnosis: what is on the market?

Minion J, Sohn H, Pai M.

Expert Rev Med Devices. 2009 Jul;6(4):341-5. doi: 10.1586/erd.09.26. Review. No abstract available. Erratum in: Expert Rev Med Devices. 2009 Sep;6(5):596.

PMID:
19572787
46.

Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae pre- and post-seven valent pneumococcal conjugate vaccine introduction in Alberta, Canada, 2000-2006.

Tyrrell GJ, Lovgren M, Chui N, Minion J, Garg S, Kellner JD, Marrie TJ.

Vaccine. 2009 Jun 2;27(27):3553-60. doi: 10.1016/j.vaccine.2009.03.063. Epub 2009 Apr 18.

PMID:
19464534
47.

Diagnostics for tuberculosis: what new knowledge did we gain through The International Journal of Tuberculosis and Lung Disease in 2008?

Minion J, Zwerling A, Pai M.

Int J Tuberc Lung Dis. 2009 Jun;13(6):691-7. Review. No abstract available.

PMID:
19460243

Supplemental Content

Loading ...
Support Center